Centre to prohibit online pharmacies due to concerns about the misuse of user data

Share via:

The Centre is reportedly considering prohibiting online pharmacies due to concerns about the misuse of user data. According to sources, a Group of Ministers (GoM) has advocated for the closure of such platforms due to alleged industry malpractices and concerns about data privacy, predatory pricing, and the sale of medicines without prescriptions.

The development will have an immediate impact on the healthtech space, which is dominated by startups like Tata 1mg, NetMeds, PharmEasy, Flipkart, and Amazon.

According to one report, no firm decision has been made on the matter. According to a source, it is critical for the government to find solutions before giving the industry the green light.

This comes just a month after the Drugs Controller General of India (DCGI) issued notices to as many as 20 epharmacies for violating Drugs and Cosmetics Act, 1940 regulations.

The notice, which was sent to almost all major epharmacies, including Tata 1mg, Amazon, and Flipkart, asked these companies to explain why no action should be taken against them for breaking the rules.

Following that, reports surfaced that the Ministry of Health was considering harsh action, including a complete ban, against online pharmacies for delivering medicines without prescriptions and for data privacy concerns.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Centre to prohibit online pharmacies due to concerns about the misuse of user data

The Centre is reportedly considering prohibiting online pharmacies due to concerns about the misuse of user data. According to sources, a Group of Ministers (GoM) has advocated for the closure of such platforms due to alleged industry malpractices and concerns about data privacy, predatory pricing, and the sale of medicines without prescriptions.

The development will have an immediate impact on the healthtech space, which is dominated by startups like Tata 1mg, NetMeds, PharmEasy, Flipkart, and Amazon.

According to one report, no firm decision has been made on the matter. According to a source, it is critical for the government to find solutions before giving the industry the green light.

This comes just a month after the Drugs Controller General of India (DCGI) issued notices to as many as 20 epharmacies for violating Drugs and Cosmetics Act, 1940 regulations.

The notice, which was sent to almost all major epharmacies, including Tata 1mg, Amazon, and Flipkart, asked these companies to explain why no action should be taken against them for breaking the rules.

Following that, reports surfaced that the Ministry of Health was considering harsh action, including a complete ban, against online pharmacies for delivering medicines without prescriptions and for data privacy concerns.

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

As generative AI gets better, what will happen to...

Suno CEO Mikey Shulman found himself in an...

Nodal connects hopeful parents with surrogates as reproductive freedom...

Many people who want to have children can’t,...

Elon Musk’s false and misleading election claims have been...

The world’s richest man buys out one of...

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!